Search results for "Infectious Diseases"
Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare
A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021
Latest COVID-19 research looks at obesity, AKI, nursing home prescribing, symptom checkers
Acute kidney injury (AKI) may have more severe consequences after COVID-19, nursing home residents received risky drugs during the pandemic, and an online symptom checker didn't triage safely, but preprocedural COVID-19 testing showed that vaccinations reduced asymptomatic infections.
https://immattersacp.org/weekly/archives/2021/03/16/1.htm
16 Mar 2021
NIH adds another antibody to recommended treatments, studies look at early cases, racial disparities
Recent COVID-19 news includes a new NIH recommendation and studies of the earliest U.S. cases, an experimental inpatient drug, and potential causes of racial disparities in outcomes.
https://immattersacp.org/weekly/archives/2021/06/22/1.htm
22 Jun 2021
Comprehensive study finds vaccines remarkably safe
The most common safety issue that resulted in label changes for vaccines was a restriction on the population to be vaccinated, such as pregnant or immunocompromised patients.
https://immattersacp.org/weekly/archives/2020/07/28/4.htm
28 Jul 2020
Boosters, convalescent plasma, long-term effects, and other COVID-19 news
Government officials announced that they plan to offer booster shots for the mRNA COVID-19 vaccines. Convalescent plasma didn't improve outcomes for high-risk outpatients in a trial, and two studies reported long-term effects of hospitalization for COVID-19.
https://immattersacp.org/weekly/archives/2021/08/24/1.htm
24 Aug 2021
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
Delayed antibiotics for upper respiratory tract infections associated with infection-related hospital admissions
Delayed prescribing should be better targeted to patients with lower risks of complications, the study authors wrote.
https://immattersacp.org/weekly/archives/2020/07/07/5.htm
7 Jul 2020
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
COVID-19 research covers taste and smell alterations, incidence in nursing homes and shelters, resource allocation policies
Other topics of note this week include guidance from the Infectious Diseases Society of America (IDSA) on personal protective equipment, plus information from the FDA and IDSA on serum antibody tests.
https://immattersacp.org/weekly/archives/2020/04/28/1.htm
28 Apr 2020
New data on delta variant of COVID-19 and vaccines
Recent research found that the risk of myocarditis and both arterial and venous clots is higher with COVID-19 infection than with vaccine administration. Other studies show that the COVID-19 delta variant has been associated with reduced mRNA vaccine effectiveness (from 91% to 66%) and an overall increased severity of illness.
https://immattersacp.org/weekly/archives/2021/08/31/1.htm
31 Aug 2021